2024 annual financial data
Cellyan Biotechnology 2024 Operating income
Direct answer
Operating income was 1,608,261 USD.
Operating income was 1,608,261 USD and net income was 1,329,717 USD.
Operating cash flow was -394,330 USD.
Get free Cellyan Biotechnology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 16,688,364 USD
- Operating income
- 1,608,261 USD
- Net income
- 1,329,717 USD
- Operating cash flow
- -394,330 USD